Clinical Trial Update: Travoprost Five Day Posology Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating five-day posology of travoprost in open-angle glaucoma and ocular hypertension. The study results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma (OAG), Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2011-06-23